Skip to main content
Bioengineered logoLink to Bioengineered
. 2023 Oct 18;14(1):2269351. doi: 10.1080/21655979.2023.2269351

Statement of Retraction: N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner

PMCID: PMC10588532  PMID: 37853771

The Publisher of the journal Bioengineered, have retracted the following article:

Miao YQ, Chen W, Zhou J, Shen Q, Sun Y, Li T, Wang SC. N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner. Bioengineered. 2022 Jan;13(1):1858-1871. doi: 10.1080/21655979.2021.2018386.

Since publication, significant concerns have been raised about the compliance with ethical policies for human research and the integrity of the data reported in the article.

When approached for an explanation, the authors provided some original data but were not able to provide all the necessary supporting information. As verifying the validity of published work is core to the scholarly record’s integrity, we are retracting the article. All authors listed in this publication have been informed.

We have been informed in our decision-making by our editorial policies and the COPE guidelines.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted.’


Articles from Bioengineered are provided here courtesy of Taylor & Francis

RESOURCES